Gain critical insights and in-depth knowledge from leading figures in cardiometabolic, cardiorenal, and cardiovascular health – at your own pace.

Webinar Spotlight

Cardiovascular Disease in the South Asian/Asian American Population

Kris Vijay, MD, MS

This one-hour webinar from Cardiometabolic Health Congress (CMHC) faculty member Dr. Kris Vijay provided insights on pertinent topics in the cardiovascular care of patients of Asian and South Asian descent. Recorded on May 25, 2023.

The Buzz with Newer Weight Loss Treatments

Fatima Stanford
Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS
Shasa Hu, MD
Shasa Hu, MD

This joint webinar by LiVDERM and Cardiometabolic Health Congress covered recent advances in obesity treatments, how this is relevant to the quality of life, including current challenges and controversies in the news, and how the new therapies affect facial/body aging. Recorded on Mar. 8, 2023

Accelerating Diversity, Equity, and Inclusion in Cardiometabolic Health: Latest Updates from Leaders in the Field

Keith C. Ferdinand, MD
Keith C. Ferdinand, MD
James R. Gavin III, MD, PhD
James R. Gavin III, MD, PhD
Rachel M. Bond, MD

During this webinar, Dr. Ferdinand led a discussion with Drs. James Gavin and Rachel Bond about the importance of diversity and inclusion in cardiometabolic health, with a focus on social determinants of health in managing diabetes, managing women’s cardiovascular risk across the lifespan, as well as strategies for multidisciplinary collaboration. Recorded on Feb. 16, 2023

Cardiovascular Health of LGBTQ Populations

Carl G. Streed, Jr., MD, MPH
Further your understanding and expand your ability to provide care to members of the LGBTQ patient population. Dr. Streed presents mounting evidence that lesbian, gay, bisexual, transgender, and queer or questioning (LGBTQ) adults experience disparities across several cardiovascular risk factors when compared with their cisgender heterosexual peers. These disparities are posited to be driven primarily by exposure to psychosocial stressors across the lifespan. Recorded on Dec. 7, 2022

Lipids in Women Across the Life Cycle

Join Dr. Michos as she presents the latest data, along with her expert insights, on how conditions such as familial hypercholesterolemia (FH) and dyslipidemia affect women throughout their lifespans. Take away principles you can apply immediately to women of all ages with high lipid levels, from child-bearing age through menopause and beyond.

Nutrition and Cardiovascular Mortality

Kim A. Williams, Sr., MD
Kim A. Williams, Sr., MD
Internationally recognized cardiologist and past president of the American College of Cardiology, Dr. Williams discusses the impacts of nutrition on cardiovascular mortality, as well as commonsense nutritional approaches that have been proven to reduce the disease burden in high-risk cardiometabolic patients. For patients with cardiovascular disease and related risk factors, Dr. Williams covers the pros and cons of plant-based, low-carb, and other dietary strategies to reduce the risk of adverse cardiovascular events.

Looming Cardiometabolic Crisis: a Conversation About Race

Alanna A. Morris, MD, MSc
Alanna A. Morris, MD
Keith C. Ferdinand, MD
Keith C. Ferdinand, MD
Rachel M. Bond, MD
Despite therapeutic advances, the cardiometabolic disease burden remains disproportionally high in patients from racial and ethnic populations. The reasons for these disparities are complex and underlined by social determinants of health and limited access to appropriate health care, among other factors. During this webinar, Dr. Ferdinand and a panel of key opinion leaders discuss the current state of these disparities as well as strategies to better help close these gaps going forward. Recorded on Feb. 22, 2022.

Cardiometabolic Health Disparities in Hispanic Americans

Alexandra Salcedo, RDN
Alexandra Salcedo, RDN
Veronica Vital, PhD.
Experts discuss the disparities that exist in cardiovascular and cardiometabolic risk factors in Hispanic populations, as well as the role of providing individualized nutrition advice to help address some of these disparities. Recorded on Oct. 8, 2021.

Cardiac TTR Amyloidosis: Contemporary Diagnosis and Therapy

Prem Soman, MD, PhD, FRCP, FACC
Prem Soman, MD, PhD, FRCP, FACC
Join Dr. Soman, associate professor of medicine and director of the Cardiac Amyloidosis Center at the University of Pittsburgh Medical Center, as he reviews the diagnosis and treatment for transthyretin amyloid cardiomyopathy, an underdiagnosed and potentially fatal disease.

Evolving Lipid Management

Christie M. Ballantyne, MD
Christie M. Ballantyne, MD
Renowned Baylor cardiologist and CMHC chairperson Dr. Ballantyne discusses cardiovascular disease prevention in the cardiometabolic patient as they pertain to cholesterol and comprehensive primary prevention guidelines. He also addresses the evolution of lipid therapy and lipid targets, the role of lipoprotein(a) and hypertriglyceridemia in treatment and prevention, and lifestyle and obesity management.

The Importance of Navigating Female Cardiometabolic Care

Pam Taub, MD, FACC
Providers face unique challenges when providing cardiometabolic health care to women. Learn about sex-specific risk factors and unique cardiometabolic considerations in women from Dr. Taub, associate professor of medicine in the Division of Cardiovascular Medicine at the University of California San Diego presents pearls for best practices to actively engage patients and the community in the prevention of cardiovascular disease in women.

The Emerging Role of Technology in Type 2 Diabetes Management

Anne L. Peters, MD
Diabetes expert and CMHC chairperson Dr. Anne L. Peters discusses why we need to look beyond HbA1c as a target, particularly for patients with cardiovascular risk, and how technology can help improve outcomes. Dr. Peters also discusses practical steps and strategies to optimize the use of technology, including CGM devices, for diabetes management in everyday practice.

Cardio-Renal Benefits with GLP-1 RAs and SGLT-2 Inhibitors

George L. Bakris, MD
George Bakris, MD
As CMHC chairperson and professor of medicine and director of the Comprehensive Hypertension Center within the Section of Endocrinology, Diabetes and Metabolism at the University of Chicago Medicine, Dr. Bakris is one of the leading experts on the relationship between heart and kidney health. Listen as he reviews recent data about the cardiorenal benefits of glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose co-transporter 2 (SGLT-2) inhibitors in patients with diabetes, and what this means to the practicing clinician.

The Management of Hypertriglyceridemia

Robert H. Eckel, MD
Join Dr. Eckel for an examination of the potential causes of hypertriglyceridemia, considerations for patients with the disease, and how clinicians can appropriately screen, diagnose, manage, and treat patients with even severe forms of the disease.

NASH in a Dash

Christos S. Mantzoros, MD
The increasing prevalence of nonalcoholic fatty liver disease (NAFLD), which leads to nonalcoholic steatohepatitis (NASH), is of clinical significance to cardiometabolic providers. Dr. Mantzoros covers potential complications, currently available treatments, and what the future holds for patients with NASH.

Coronary Artery Disease in South Asians

Navin C. Nanda, MD
Join Dr. Nanda, distinguished professor of medicine and cardiovascular disease from University of Alabama at Birmingham, in a conversation centering around the prevalence, risk factors, screening, and treatment for coronary artery disease (CAD) in the South Asian population.

Emerging Approaches to LDL-C Lowering

Christie M. Ballantyne, MD
Christie M. Ballantyne, MD
Listen to renowned lipids expert and CMHC chairperson, Dr. Ballantyne, review the rationale and evidence for emerging low-density lipoprotein cholesterol (LDL-C) lowering agents, including inclisiran and bempedoic acid, as well as their potential practice implications in the near future.

Challenge of Cardiovascular Risk Reduction in Racial and Ethnic Minorities

Keith C. Ferdinand, MD
Keith C. Ferdinand, MD
Dr. Ferdinand, CMHC Senior Planning Committee member and professor of medicine at Tulane University School of Medicine, reviews the impact of ethnicity and race on individuals’ risk of developing cardiovascular disease. He presents evidence of gaps in life expectancy, cognitive function, body weight, blood pressure, and many other markers of health among Black, Hispanic, and other racial and ethnic minority populations.

The Novel Coronavirus: Going Viral

Gregory Poland, MD
Sit down with distinguished investigator and director of Mayo Clinic’s Vaccine Research Group, to learn what physicians need to know about the novel coronavirus outbreak. Dr. Poland covers the gastrointestinal and respiratory effects of COVID-19, and what clinicians should know about using antiviral, steroidal, and other therapies to combat the virus in their patients with cardiometabolic diseases.

Antithrombotic Therapy In Diabetes Patients

Deepak Bhatt MD, MPH
As a CMHC Senior Planning Committee member and renowned physician and researcher, Dr. Bhatt has unique insights into the safety and efficacy of using antithrombotic agents in patients with diabetes. In this webinar, he discusses the results of THEMIS and THEMIS-PCI studies and their clinical practice implications.

Lifestyle Approaches to Weight Reductions: Challenges and Opportunities

Holly Wyatt, MD
As Vice Chair of Clinical Programs in the Department of Nutrition Sciences at the University of Alabama Birmingham, Dr. Wyatt is an expert in the challenges faced by physicians when counseling their patients with overweight or obesity. Here, she provides practical tips to curb the obesity epidemic, including successful assessment strategies, the role of nutrition and exercise, and strategies to maintain weight loss.

Use of Continuous Glucose Monitoring in Cardiovascular and Pulmonary Rehabilitation

Anne L. Peters, MD
Listen to diabetes expert speaker, clinician, and CMHC chairperson, Dr. Peters discuss the role of continuous glucose monitoring devices in optimizing glucose control. She also covers the role of exercise and nutrition basics for patients with diabetes who’ve undergone cardiopulmonary rehabilitation.

REDUCE-IT: Data, Cost-Effectiveness, and Guidelines

Deepak Bhatt MD, MPH
While hypercholesterolemia is an important and modifiable risk factor in reducing atherosclerotic cardiovascular disease (ASCVD) risk, there may be residual risk present even after optimization of cholesterol levels. Dr. Bhatt, a principal investigator in the REDUCE-IT trial, reviews the use of icosapent ethyl to reduce atherosclerotic events in high-risk patients with clinical ASCVD or type 2 diabetes and additional markers of increased risk.

Therapeutic Carbohydrate Restriction for Type 2 Diabetes

Amy McKenzie, PhD
Sarah Hallberg DO, MS, ACSM – CEP, FNLA, FOMA
Drs. McKenzie and Hallberg present evidence comparing ketogenic, low-carbohydrate, and restricted-calorie diets to improve glucose levels in patients with type 2 diabetes. General nutritional guidelines and strategies for preventing hypoglycemia are covered, as well as gender- and weight-specific factors clinicians must consider when recommending dietary changes.


Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.